BALAXI PHARMACEUTICALS
|
The Current P/E Ratio of BALAXI PHARMACEUTICALS is 12.00.
Share Price | ₹54.5 | Jun 11,2025 |
Market Cap | ₹300.8 Cr | |
Earnings-TTM | ₹25.1 Cr | TTM-Consolidated Results |
Price/Earnings | 12.00x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹300.8 Cr] as on Jun 11,2025
(/) Earnings [ ₹25.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 12.00x ]
Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 12.00 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS
PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS
- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.11x.
- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.
- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?
Peer Comparison (Trading Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BALAXI PHARMACEUTICALS | 25.07 | 12.00 | 300.8 |
ADANI ENTERPRISES LTD | 7,510.22 | 39.05 | 293,295.0 |
REDINGTON LTD | 1,820.62 | 12.86 | 23,406.3 |
MMTC LTD | 69.53 | 153.84 | 10,696.5 |
HONASA CONSUMER LTD | 72.69 | 139.56 | 10,144.1 |
LLOYDS ENTERPRISES LTD | 126.30 | 73.28 | 9,254.7 |
ENTERO HEALTHCARE SOLUTIONS LTD | 107.43 | 48.47 | 5,206.9 |
OPTIEMUS INFRACOM LTD | 60.00 | 86.71 | 5,202.0 |
POLO QUEEN INDUSTRIAL & FINTECH LTD | 2.64 | 767.81 | 2,026.3 |
MSTC LTD | 435.68 | 8.71 | 3,795.3 |
SG MART LTD | 103.40 | 49.96 | 5,165.4 |
Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 8.71x |
Max industry PE | 767.81x |
Median industry PE | 49.96x |
Average industry PE | 126.57x |
You may also like the below Video Courses